CAD 0.35
(12.9%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 517.08 Thousand CAD | 61.35% |
2022 | 320.46 Thousand CAD | -72.79% |
2021 | 1.17 Million CAD | 308.42% |
2020 | 288.4 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 382.71 Thousand CAD | -25.99% |
2023 Q3 | 485.32 Thousand CAD | -15.63% |
2023 FY | 517.08 Thousand CAD | 61.35% |
2023 Q1 | 310.06 Thousand CAD | -3.25% |
2023 Q4 | 517.08 Thousand CAD | 6.54% |
2023 Q2 | 575.23 Thousand CAD | 85.52% |
2022 Q3 | 409 Thousand CAD | -23.15% |
2022 FY | 320.46 Thousand CAD | -72.79% |
2022 Q4 | 320.46 Thousand CAD | -21.65% |
2022 Q2 | 532.24 Thousand CAD | 66.08% |
2022 Q1 | 320.46 Thousand CAD | -72.79% |
2021 FY | 1.17 Million CAD | 308.42% |
2021 Q3 | 2.02 Million CAD | 0.0% |
2021 Q4 | 1.17 Million CAD | -41.84% |
2020 FY | 288.4 Thousand CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
AI/ML Innovations Inc. | 329.68 Thousand CAD | -56.84% |
Diagnamed Holdings Corp. | 662.27 Thousand CAD | 21.922% |
Pangenomic Health Inc. | 71.47 Thousand CAD | -623.417% |
nDatalyze Corp. | 877.9 Thousand CAD | 41.1% |
Treatment.Com International Inc. | 739.3 Thousand CAD | 30.058% |